FDA Approves Decapinol Oral Rinse to Help Treat Gingivitis

Main Category: Dentistry
Article Date: 19 Apr 2005 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:3 and a half stars

3.5 (6 votes)

Healthcare Prof:4 stars

3.67 (3 votes)


The Food and Drug Administration (FDA) today approved a new prescription treatment for gingivitis, a common gum disease that affects most adults at some point in their lives. The Decapinol Oral Rinse treats gingivitis by reducing the number of bacteria that attach to tooth surfaces and cause dental plaque. Decapinol is approved for use in persons 12 years of age or older when routine oral hygiene is not adequate to prevent gingivitis. Decapinol is not recommended for use by pregnant women.

"This new dental rinse helps treat gingivitis when tooth brushing and flossing are not enough," said Dr. Daniel Schultz, Director of FDA's Center for Devices and Radiological Health. "This product can lead to a substantial reduction in gingivitis."

Gingivitis is an inflammation of the gums that often appears as swollen, red, or bleeding gums. Scientists believe plaque-forming bacteria that live in the mouth and on tooth surfaces are a cause of gingivitis. Substances released by the bacteria cause the gum inflammation. Reduction of plaque bacteria can decrease the inflammatory substances and cause a reduction in gingivitis.

Clinical studies were conducted in adults with mild to severe gingivitis. In these studies, Decapinol was compared either to "no treatment" or to an antimicrobial rinse. The studies showed that Decapinol decreases gingivitis up to 60%--compared to no treatment and when used as instructed with recommended brushing and flossing.

Decapinol Oral Rinse is being regulated as a medical device and not as a drug because its primary mode of action is to create a physical barrier, rather than to act chemically. Decapinol contains a substance called a surfactant that acts as a physical barrier, making it harder for bacteria to stick to tooth surfaces. FDA also has approved a number of other anti-gingivitis oral rinses, but since these products act chemically to kill bacteria that live in the mouth, they are regulated as antimicrobial drugs rather than as devices.

Decapinol Oral Rinse is manufactured by Sinclair Pharmaceuticals Limited, based in the United Kingdom. www.sinclairpharma.com/index.cfm

http://www.fda.gov

Article adapted by Medical News Today from original press release.
Visit our dentistry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christian Nordqvist. "FDA Approves Decapinol Oral Rinse to Help Treat Gingivitis." Medical News Today. MediLexicon, Intl., 19 Apr. 2005. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/23077.php>

APA
Christian Nordqvist. (2005, April 19). "FDA Approves Decapinol Oral Rinse to Help Treat Gingivitis." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/23077.php.

Please note: If no author information is provided, the source is cited instead.


Dentistry

Most Popular Articles



Follow Our Dentistry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Dentistry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »